6-Bromo-N-butyl-1H-benzo[d]imidazol-2-amine

ID: ALA4776136

PubChem CID: 82564717

Max Phase: Preclinical

Molecular Formula: C11H14BrN3

Molecular Weight: 268.16

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCCCNc1nc2ccc(Br)cc2[nH]1

Standard InChI:  InChI=1S/C11H14BrN3/c1-2-3-6-13-11-14-9-5-4-8(12)7-10(9)15-11/h4-5,7H,2-3,6H2,1H3,(H2,13,14,15)

Standard InChI Key:  QJQZIFLYRSNKLG-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 15 16  0  0  0  0  0  0  0  0999 V2000
    1.5068  -25.3079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5057  -26.1353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2205  -26.5481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2188  -24.8952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9341  -25.3042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9343  -26.1353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7248  -26.3919    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2131  -25.7193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7244  -25.0473    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0373  -25.7219    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4519  -25.0087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2769  -25.0113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6916  -24.2980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5166  -24.3005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7923  -24.8956    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
  1 15  1  0
M  END

Alternative Forms

Associated Targets(Human)

RIPK1 Tchem Receptor-interacting serine/threonine-protein kinase 1 (1548 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 268.16Molecular Weight (Monoisotopic): 267.0371AlogP: 3.54#Rotatable Bonds: 4
Polar Surface Area: 40.71Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 12.16CX Basic pKa: 6.92CX LogP: 3.51CX LogD: 3.39
Aromatic Rings: 2Heavy Atoms: 15QED Weighted: 0.83Np Likeness Score: -1.22

References

1. Benchekroun M,Ermolenko L,Tran MQ,Vagneux A,Nedev H,Delehouzé C,Souab M,Baratte B,Josselin B,Iorga BI,Ruchaud S,Bach S,Al-Mourabit A.  (2020)  Discovery of simplified benzazole fragments derived from the marine benzosceptrin B as necroptosis inhibitors involving the receptor interacting protein Kinase-1.,  201  [PMID:32659605] [10.1016/j.ejmech.2020.112337]

Source